The New Skin Cancer Drugs Approved - Medicines regulatory body the United States, the FDA, has approved the first drug ever shown to help people who suffer from a type of deadly skin cancer live longer.
Richard Pazdur of the FDA issued a statement Friday saying that the advanced-stage melanoma skin cancer is very grave and few alternative treatment - and more and more people are diagnosed with cancer every year.
Last year, approximately 68 thousand people are diagnosed in the United States with fast-moving cancer that was - and about 8,700 people died.
Biotech drug that works by strengthening the immunity of patients, cancer by inhibiting the molecule to cause interferences, allowing white blood cells back into action and kill cancer cells.
Developer drug was "Bristol Myers Squibb" drug test that can be injected in patients who can no longer be given other drugs - a group of people who have very low life expectancy. The FDA said people get a new drug that the average life of approximately 4 months longer than those who did not receive the new drug, and some patients live many years longer.
Doctors say the new drug, which is also called by its generic name "Ipillmumab," is the first step in improving treatment of patients with melanoma, and further development of the drug was being done.
Richard Pazdur of the FDA issued a statement Friday saying that the advanced-stage melanoma skin cancer is very grave and few alternative treatment - and more and more people are diagnosed with cancer every year.
Last year, approximately 68 thousand people are diagnosed in the United States with fast-moving cancer that was - and about 8,700 people died.
Developer drug was "Bristol Myers Squibb" drug test that can be injected in patients who can no longer be given other drugs - a group of people who have very low life expectancy. The FDA said people get a new drug that the average life of approximately 4 months longer than those who did not receive the new drug, and some patients live many years longer.
Doctors say the new drug, which is also called by its generic name "Ipillmumab," is the first step in improving treatment of patients with melanoma, and further development of the drug was being done.